Zelira Therapeutics Ltd (ZLD) — Capital Reinvestment Ratio

Latest as of December 2015: 0.23x

Zelira Therapeutics Ltd (ZLD) has a Capital Reinvestment Ratio of 0.23x as of December 2015, meaning it reinvests 0% of its operating cash flow (AU$159.61K) in capital expenditures (AU$36.80K). Check ZLD intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.23x
Capex / Operating Cash Flow

Operating Cash Flow

AU$159.61K
AUD

Capital Expenditures

AU$36.80K
AUD

Data as of

Dec 2015
Most recent filing

Zelira Therapeutics Ltd Capital Reinvestment Ratio (2011–2011)

This chart tracks Zelira Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ZLD operating cash flow.

Annual Capital Reinvestment Ratio for Zelira Therapeutics Ltd (2011–2011)

Year-by-year Capital Reinvestment Ratio for Zelira Therapeutics Ltd from 2011 to 2011. See Zelira Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2011 0.14x AU$101.92K AU$13.95K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow